Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neurofibromatosis 1 2Neoplasms 2Smoking Cessation 1Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Cognition Disorders 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1Anxiety Disorders 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1Agnosia 1Abdominal Pain 1

Interventions

Tobacco Use Cessation Devices 4Surveys and Questionnaires 4Varenicline 2Tobacco Products 2Smoking Devices 2Ethanol 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Transcranial Direct Current Stimulation 1Restraint, Physical 1Radon 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Mindfulness 1Interviews as Topic 1Health 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cognitive Behavioral Therapy 1Cetuximab 1Bupropion 1Budesonide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Smoking × Transcranial Direct Current Stimulation × Clear all
NCT05460676 2026-04-24

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Wake Forest University Health Sciences

Phase NA Completed
43 enrolled

Anxiety Disorders, Neoplasms, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡